Regenxbio stock rises on FDA’s priority review for MPS II therapy
-- Shares of Regenxbio Inc . (NASDAQ:RGNX) climbed 7.2% in premarket trading after the company announced the U.S....
-- Shares of Regenxbio Inc . (NASDAQ:RGNX) climbed 7.2% in premarket trading after the company announced the U.S....
-- Shares of iTeos Therapeutics, Inc. (NASDAQ:ITOS) climbed 11% today, even as the company announced the termination...
-- HSBC has downgraded Chevron (NYSE:CVX) from Buy to Hold, citing reduced valuation upside and a cut to...
Victoria, Seychelles, May 13th, 2025, Chainwire As centralized exchanges and On-chain Trading edge closer to integration, global...
-- Apple (NASDAQ:AAPL) is stepping into the realm of brain-computer interfaces (BCIs), a move that could potentially...
-- German Chancellor Friedrich Merz expressed caution regarding the use of debt-funded financing instruments by the...
-- RBC Capital Markets has initiated coverage on two major European building materials firms, Sika (SIX:SIKA) AG and...
Willemstad, Curaçao, May 12th, 2025, Chainwire “Canelo chooses victory, while 1win chooses the best!” said the...
RIYADH (Reuters) -BlackRock CEO Larry Fink says tens of trillions of dollars of financial firepower is sitting idle in cash amid...
By Maggie Fick (Reuters) -U.S. President Donald Trump signed a broad executive order on Monday directing drugmakers to lower the...